This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
Product | Active Ingredient(s) |
Allopurinol Teva 300mg Tablets PA0749/099/003 Teva Pharma B.V. | Allopurinol |
Aminophylline Hydrate 25mg/ml Solution for Injection PA0073/099/001 Mercury Pharmaceuticals (Ireland) Ltd | Aminophylline Hydrate |
Atozet 10mg/10mg Film Coated Tablets PA23198/022/01 Organon Pharma (Ireland) Limited | Ezetimibe & atorvastatin |
Atozet 10mg/20mg Film Coated Tablets PA23198/022/002 Organon Pharma (Ireland) Limited | Ezetimibe & atorvastatin |
Azyter 15 mg/g Eye Drops PA1107/004/001 Laboratoires Thea | Azithromycin |
Benylin Children’s Dry Coughs Syrup PA0330/022/001 Johnson & Johnson (Ireland) Limited | Diphenhydramine & levomenthol |
Benylin Cough Medicine Syrup PA0330/019/001 Johnson & Johnson (Ireland) Limited | Diphenhydramine & levomenthol |
Caelyx pegylated liposomal 2mg/ml (25ml presentation) EU/1/96/011/003-004 Baxter Holding B.V. | Doxorubicin |
Canesten 500mg Pessary PA1410/039/009 Bayer Limited | Clotrimazole |
Canesten Combi Pessary & Cream PA1410/039/001 Bayer Limited | Clotrimazole |
Flutiform 125 microgram/5 microgram per metered dose Pressurised Inhalation, Suspension PA1688/013/002 Mundipharma Pharmaceuticals Limited | Fluticasone & formoterol |
Gonal-F EU/1/95/001/025 Merck Europe B.V. | Follitropin alfa |
Migraleve Film Coated Tablets PA0330/030/003 Johnson & Johnson (Ireland) Limited | Buclizine, paracetamol & codeine |
Moviprep Orange Powder for Oral Solution PA1336/001/002 Norgine B.V. | Macrogol 3350 |
Neurostil 100mg Capsules PA0749/164/001 Teva Pharma B.V. | Gabapentin |
Neurostil 400 mg capsules PA0749/164/003 Teva Pharma B.V | Gabapentin |
Nebivolol Teva 5mg Tablets PA0749/078/001 Teva Pharma B.V. | Nebivolol |
Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml Nasal Spray, Solution PA0678/131/001 GlaxoSmithKline Consumer Healthcare (Ireland) Limited | Xylometazoline & ipratropium bromide |
Otrivine Sinusitis Relief 0.1% w/v Nasal Spray, Solution PA0678/120/003 GlaxoSmithKline Consumer Healthcare (Ireland) Limited | Xylometazoline |
OxyNorm Dispersa 5mg Orodispersible Tablets PA1688/006/007 Mundipharma Pharmaceuticals Limited | Oxycodone |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
Product | Active Ingredient(s) |
Distaclor 125mg/5ml Granules for Oral Suspension PA1226/001/002 Flynn Pharma Limited | Cefaclor |
Distaclor 250mg/5ml Granules for Oral Suspension PA1226/001/003 Flynn Pharma Limited | Cefaclor |
Ilvico Cold and Flu Film Coated Tablets PA22703/001/001 P&G Health Germany GmbH | Paracetamol, brompheniramine & caffeine |
Ixiaro EU/1/08/501/1-2 Intercell Austria AG | Inactivated je virus |
Mestinon 60mg Tablets PA2010/052/001 Mylan IRE Healthcare Limited | Pyridostigmine |
Metformin Hydrochloride 500mg/5ml Oral Solution PA23081/008/001 Taw Pharma (Ireland) Ltd | Metformin |
Optiray 300 mg I/ml PFS solution for injection PA0686/007/004 Guerbet | Ioversol |
Spasmonal Forte 120mg Hard Capsules PA2010/043/002 Mylan IRE Healthcare Limited | Alverine |
Tritace 10mg Tablets PA0540/084/008 Sanofi-Aventis Ireland Limited T/A SANOFI | Ramipril |
Warfant 5mg Tablets PA0073/139/003 Mercury Pharmaceuticals (Ireland) Ltd | Warfarin |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.